Increased uterine vascular permeability and angiogenesis are hallmarks of implantation and placentation. These events are profoundly influenced by vascular endothelial growth factor (VEGF). Although VEGF and its receptor Flk-1 are primarily important for uterine vascular permeability and angiogenesis before and during the attachment phase of the implantation process, VEGF together with the angiopoietins and their receptor Tie-2 directs angiogenesis during decidualization after implantation. Uterine expression of HIF and ARNT follows the localization of VEGF expression with increasing angiogenesis during the postimplantation period, although their expression does not correlate with VEGF expression during the pre-implantation period. Upstream of VEGF, estrogen promotes uterine vascular permeability but inhibits angiogenesis, whereas progesterone stimulates angiogenesis with little effect on vascular permeability. Furthermore, COX-2-derived prostaglandins participate in uterine vascular permeability and angiogenesis during implantation and decidualization. (Reprod Med Biol 2006; 5: 81-86) 
INTRODUCTION
A NGIOGENESIS IS A hallmark event during implantation and decidualization. Under physiological conditions, angiogenesis, the process by which new blood vessels develop from pre-existing vessels, primarily occurs in the uterus and ovaries of adult women during the reproductive cycle and pregnancy.
1 Indeed, increased vascular permeability and angiogenesis are crucial to successful implantation, decidualization, and placentation. A number of studies provided indirect and descriptive evidence for the potential roles of estrogen and progesterone in these processes in various species. [1] [2] [3] These studies primarily examined the changes in the whole uterus of the expression of a number of gene products known to regulate vascular permeability and angiogenesis, including VEGF and its receptors, without investigating its angiogenic status. Thus, in vivo roles for estrogen and progesterone in uterine angiogenesis are not fully appreciated. The present review of the uterine angiogenesis during implantation and decidualization process focuses on the molecular basis of angiogenic factors, steroid hormones and prostaglandins for uterine receptivity.
ANGIOGENIC FACTORS AND THEIR RECEPTORS REQUIRED IN UTERINE ANGIOGENESIS
G ENES ENCODING MURINE vascular endothelial growth factor (VEGF) isoforms and their receptors (Flk-1, Flt-1 and Nrp1) are differentially expressed in the mouse uterus in a spatiotemporal manner during implantation and the predominant VEGF 164 isoform interacts with Flk-1 and Nrp1.
2,3 These results suggest that the VEGF system is important for uterine vascular permeability and angiogenesis during implantation.
Vascular endothelial growth factor
Vascular endothelial growth factor, originally discovered as a vascular permeability factor, is also a potent mitogen for endothelial cells and a key regulatory growth factor for vasculogenesis and angiogenesis. 4 Targeted disruption of even one allele of the Vegf gene 
Flk-1
Flk-1 is the major transducer of VEGF signals that induce chemotaxis, actin reorganization and proliferation of endothelial cells. 4, 8, 9 Targeted deletion of the Flk-1 gene in mice produces defects in hematopoietic and endothelial cell development, leading to embryonic death by day 9.5. 10 In the mouse uterus, very low to undetectable levels of expression of Flk-1 mRNA were noted on the first two days of pregnancy.
2 On days 3 and 4, these Flk-1 were distinctly expressed in cells in the stromal bed. The expression of Flk-1 mRNA was evident in stromal cells close to, but not immediately surrounding, the implanting blastocyst on day 5. On days 6-8, Flk-1 mRNA accumulation occurred in cells at both the mesometrial and antimesometrial decidual beds. However, the expression was more intense at the mesometrial pole, the presumptive site of placentation and heightened angiogenesis. On day 8, some embryonic cells also exhibited clear accumulation of this mRNA. Flk-1 was absent in the primary decidual zone (PDZ), which is avascular.
2,11
Flt-1 In the peri-implantation mouse uterus, expression levels of Flt-1 detected by northern blot hybridization and in situ hybridization were less abundant than those of Flk-1.
11

Nrp1
Another multifunctional VEGF receptor has been identified as Neuropilin-1 (Nrp1). Nrp1 was originally described as a neuronal transmembrane receptor that participates in axonal guidance in the developing nervous system 17, 18 and is a receptor for the collapsin/ semaphorin family of proteins. 19, 20 It is now known that Nrp1 functions as a receptor for at least five different ligands; collapsin-1/semaphorin-IIII/D, semaphorin-E, semaphorin-IV, VEGF 165 and placental growth factor (PlGF). These ligands are involved in different biological processes, such as nervous system development, vasculogenesis and angiogenesis. 20, 21 Nrp1 is expressed in human endothelial cells as a VEGF 165 -specific receptor. When coexpressed in endothelial cells with Flk-1, Nrp1 enhances the binding of VEGF 165 to Flk-1 and VEGF 165 -mediated chemotaxis severalfold higher than that of Flk-1 alone. 22 In contrast, inhibition of VEGF 165 binding to Nrp1 inhibits its binding to Flk-1 and its mitogenic activity in endothelial cells. Nrp1-deficient mice show peripheral nervous system abnormalities and die in midgestation as a result of yolk sac vascular insufficiency and developmental anomalies of the cardiovascular system. 23 Mice overexpressing Nrp1 also show cardiovascular abnormalities including increased number of blood vessels and abnormal hearts.
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The expression pattern of Nrp1 mRNA was similar to Flk-1. During the first two days of pregnancy, very low to undetectable levels of expression of Nrp1 mRNAs were noted in the uterus.
2 On days 3 and 4, these genes were distinctly expressed in cells in the stromal bed. The expression of Nrp1 mRNA was evident in stromal cells close to, but not immediately surrounding, the implanting blastocyst on day 5. On days 6-8, Nrp1 mRNA accumulation occurred in cells at both the mesometrial and antimesometrial decidual beds. However, the expression was more intense at the mesometrial pole, which is the presumptive site of placentation and heightened angiogenesis. On day 8, some embryonic cells also exhibited clear accumulation of this mRNA. Nrp1 was absent in the PDZ. 2, 11 This absence was also reflected in reduced levels of Nrp1 mRNA, as determined
